Amlodipine and benazepril combination therapy
Pro Research Analysisby 
Searched over 200M research papers
Blood Pressure Reduction with Amlodipine and Benazepril Combination Therapy
Studies consistently show that combining amlodipine, a calcium channel blocker, with benazepril, an ACE inhibitor, leads to greater reductions in both systolic and diastolic blood pressure compared to using either drug alone. This effect is seen in patients whose blood pressure is not adequately controlled with monotherapy, including those with severe hypertension and in both Black and White patient populations. The combination therapy results in more patients reaching target blood pressure goals and provides a stronger antihypertensive effect, especially at higher doses of the combination Chrysant2007Chrysant2004Neutel2002+3 MORE.
Efficacy Compared to Other Combination Therapies
When compared to another common dual therapy (benazepril with hydrochlorothiazide), the amlodipine/benazepril combination showed similar overall blood pressure-lowering effects. However, it provided slightly better reductions in daytime blood pressure and had a lower incidence of dry cough, a common side effect of ACE inhibitors .
Cardiovascular Protection and Structural Benefits
Beyond lowering blood pressure, the amlodipine/benazepril combination improves cardiovascular structure and function. Patients on this combination experience greater improvements in arterial stiffness and more significant regression of left ventricular hypertrophy compared to those on monotherapy. This suggests that the combination offers additional cardiovascular protection beyond just blood pressure control .
Safety and Tolerability of Amlodipine/Benazepril
The combination therapy is generally well tolerated. The incidence of common side effects, such as peripheral or pedal edema, is lower with the combination than with amlodipine alone. The rate of adverse events with the combination is often similar to that seen with placebo, and there are no significant metabolic side effects reported. In elderly patients, switching to the fixed-dose combination reduced both the number of adverse events and the cost of antihypertensive therapy, while maintaining effective blood pressure control Chrysant2007Faulkner2001Izzo2010+1 MORE.
Real-World Effectiveness and Cost Considerations
Community-based and practice-based studies confirm that the fixed-dose combination of amlodipine/benazepril is effective and well tolerated in real-world settings. It improves adherence, reduces the risk of side effects, and is more cost-effective than using the two drugs separately or as high-dose monotherapy Faulkner2001Messerli2002Sapienza2003.
Conclusion
Amlodipine and benazepril combination therapy is more effective than monotherapy with either drug for lowering blood pressure, achieving target blood pressure goals, and improving cardiovascular outcomes. It is well tolerated, reduces the risk of certain side effects, and is cost-effective, making it a strong option for patients who do not achieve adequate blood pressure control with a single medication.
Sources and full results
Most relevant research papers on this topic